Antioxidant phytochemicals and potential synergistic activities at reducing risk of cardiovascular disease

Food-Drug Synergy and Safety

Volumn , Issue , 2005, Pages 27-62

  Kitts, David D ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 73449138527     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (183)

1. Ness, A.R. and Powels, J.W., Fruit and vegetables and cardiovascular disease: a review, Int. J. Epidemiol., 26, 1, 1997.
2. Aldercreutz, H. and Mazur W., Phytoestrogens and western disease, Ann. Med., 29, 95, 1995.
3. Liu, S., Lee, I.M., Ajani, U., Cole, S.R., Buring, J.E., and Manson, J.E., Intake of vegetables rich in carotenoids and risk of cardiovascular disease in men: The Physicians’ Health Study, Int. J. Epidemiol., 30, 130, 2001.
4. Truswell, A.S., Cereal grains and coronary heart disease, Eur. J. Clin. Nutr., 56, 1, 2002.
5. Iqbal, K., Rauoff, M.A., Mir, M.M., Tramboo, N.A., Malik, J.A., Naikoo, B.C., Dar, M.A., Masoodi, S.R., and Khan, A.R., Lipid peroxidation during acute coronary syndromes and its intensification at the time of myocardial ischemia reperfusion, Am. J. Cardiol., 89, 334, 2002.
6. Uesugi, N., Sakata, N., Horiuchi, S., Nagai, R., Takeya, M., Meng, J., Saito, T., and Takebayashi, S., Glycoxidation modified macrophages and lipid peroxidation products are associated with the progression of human diabetic nephropathy, Am. J. Kidney Dis., 38, 1016, 2001.
7. Trichopoulou, A., Naska, A., Antoniou, A., Friel, S., Trygg, K., and Turrini, A., Vegetable and fruit: the evidence in their favour and the public health perspective, Inter. J. Vitamin Nutr. Res., 73, 63, 2003.
8. Marchioli, R., Antioxidant vitamins and prevention of cardiovascular disease: laboratory, epidemiological and clinical trial data, Pharmacol.Res., 40, 227, 1999.
9. Wieseman, H., Dietary influence on membrane function: Importance in protection against oxidative damage and disease. J. Nutr. Biochem., 7, 2, 1996.
10. Mosca, L., Rubenfire, M., Mandel, C., Rock, C., Tarshis, T., Tsai, A. and Pearson, T., Antioxidant nutrient supplementation reduces the susceptibility of low density lipoprotein to oxidation in patients with coronary artery disease, J. Am. Coll Cardiol., 30, 392, 1997.
11. Van’t Veer, P., Jansen, M.C.J., Klerk, M., and Kok, F., Fruits and vegetables in the prevention of cancer and cardiovascular disease. Public Health Nutr., 3, 103, 2000.
12. Brandt, K., Christenen, L.P., Hansen-Moller, H., Hansen, S.L., Haralsdottir, H., Jespersen, L., Purup, S., Kharazmi, A., Barkholt, V., Froliaer, H., and Kobaek-Larsen, M., Health promoting compounds in vegetables and fruits: A systematic approach for identifying plant components with impact on human health, Trends Food Sci. Technol., 15, 384, 2004.
13. Sesso, H.D., Gaziano, J.M., Buring, J.E., and Hennekens, C.H., Coffee and tea intake and risk of myocardial infarction, Am. J. Epidemiol 149, 162, 1999.
14. Serafini, M., Ghiselli, A., and Ferro-Luzzi, A., In vivo antioxidant effect of green and black tea in man, Eur. J. Clin. Nutr. 50, 79, 1996.
15. Cherubini, A., Beal, M.F., and Frei, B., Black tea increases the resistance of human plasma to lipid peroxidation in vitro, but not ex vivo, Free Rad. Biol. Med., 27, 381, 1999.
16. Ishikawa, T., Suzukawa, M., Toshimitsu, I., Yoshida, H., Ayori, M., Nishikawa, M., Ishikawa, M., Yonermura, A., Hara, Y., and Nakamura, H., Effect of tea flavonoids supplementation on the susceptibility of low-density lipoprotein to oxidative modification, Am. J. Clin. Nutr., 66, 261, 1997.
17. Hodgson, J.M., Odgson, J.M., Puddey, I.B., Burke, V., Beilin, L.J., and Jordan, N., Effects on blood pressure of drinking green and black tea, J. Hypertension, 17, 457, 2000.
18. Yang, T.T. and Koo, M.W., Inhibitory effect of Chinese green tea on endothelial cell-induced LDL oxidation, Atherosclerosis, 148, 67, 2000.
19. Matsumoto, N., Okushio, K., and Hara, Y., Effect of black tea polyphenols on plasma lipids in cholesterol-fed rats, J. Nutr. Sci. Vitaminol., 44, 337, 1998.
20. De Vos, S., and DeSchrijver, R., Lipid metabolism, intestinal fermentation and mineral absorption in rats consuming black tea, Nutr. Res., 23, 527, 2003.
21. Yokozawa, T., Nakagawa, T., and Kitani, K., Antioxidant activity of green tea polyphenols in cholesterol-fed rats, J. Agric. Food Chem., 50, 3549, 2000.
22. Bursill, C., Roach, P.D, Bottema, C.D. and Pal, S., Green tea up-regulates the low-density lipoprotein receptor through the sterol-regulated element binding protein in HepG2 liver cells, J. Agric. Food Chem., 49, 5639, 2001.
23. Stich, H F. and Powrie, WD., Plant phenolics as genotoxic agents and as modulators for the mutagenicity of other food components, in Carcinogens and Mutagens in the Environment, Vol. 1, Stich, H.F. (ed). CRC Press, Boca Raton, FL, 1982, pp. 136-145.
24. Laranjinha, J., Vieira, O., Madeira, V., and Almeida, L., Two related phenolic antioxidants with opposite effects on vitamin E content in low density lipoproteins oxidized by ferrylmyoglobin: consumption vs regeneration, Arch. Biochem. Biophys., 323, 373, 1995.
25. Ohnishi, M., Morishita, H., Iwahashi, H., Toda, S., Shirataka, Y., Kimura, M., and Kido, R., Inhibitory effects of chlorogenic acids on linoleic acid peroxidation and haemolysis, Phytochemistry, 36, 579, 1994.
26. Laranjinha, J.A.N., Almeida, L.M., and Madieire, V.M.C., Reactivity of dietary phenolic acids with peroxyl radicals: antioxidant activity upon low density lipoprotein peroxidation, Biochem. Pharmacol., 48, 487, 1994.
27. Millard, M.N. and Berset, C., Evalution of antioxidant activity during kilning. Role of insoluble bound phenolic acids of barley and malt, J. Agric. Food Chem., 43, 1789, 1994.
28. Miller, N.A., Diplock, A.T., and Rice-Evans, C.A., Evaluation of the total antioxidant activity as a marker of the deterioration of apple juice on storage, J. Agric. Food Chem., 43, 1794, 1994.
29. Miller, N.A. and Rice-Evans, C.A., The relative contributions of ascorbic acid and phenolic antioxidants to the total antioxidant activity of orange and apple fruit juices and black-current drink, Food Chem., 60, 331, 1997.
30. Joudad, D., Lacaille-Dubois, M.A., Lyoussi, B., and Eddouks, M., Effects of flavonoids extracted from Spergularia purpurea Pers on arterial blood pressure and renal function in normal and hypertensive rats, J. Enthopharmacol., 76, 159, 2002.
31. Steinberg, F., Bearden, M.M., and Keen, C.L., Cocoa and chocolate flavonoids: implications for cardiovascular health, J. Am. Dietetic Assoc., 103, 215, 2003.
32. Aviram, M. and Fuhrman, B., Polyphenolic flavonoids inhibit macrophagemediated oxidation of LDL and attenuate atherogenesis, Atherosclerosis, 137, S45, 1998.
33. Safari, M.R. and Sheikn, N., Effects of flavonoids on the susceptibility of lowdensity lipoprotein to oxidative modification, Prostaglandins Leukot. Essen. Fatty Acids, 69, 73, 2003.
34. Karaim, M., McCormick, K., and Kappogoda, C.T., Effects of cocoa extracts on endothelium-dependent relaxation, J. Nutr., 130, 2105S, 2000.
35. Li, I.H., Xia, N., Brausch, I., Yao, Y., and Forstermanu, U., Flavonoids from artichoke (Cynara scolymus L.) upregulate eNOS gene expression in human endothelial cells, J. Pharmacol. Exp. Ther., 310, 926, 2004.
36. Aviram, M. and Fuhrman, B., Polyphenolic flavonoids inhibit macrophagemediated oxidation of LDL and attenuate atherogenesis, Atherosclerosis 137, S45, 1998.
37. Miyazawa, T., Absorption, metabolism and antioxidant effects of tea catechins in humans, Biofactors, 13, 55, 2000.
38. Salah, N., Miller, N.J., Paganga, G., Tijburg, L., Bolwell, G. P., and Rice Evans, C., Polyphenolic flavonols as scavengers of aqueouos phase radicals and as chain-breaking antioxidants, Arch. Biochem. Biophys., 322, 339, 1995.
39. Van Het Hof, K.H., Kivitis, G.A.A., Weststrate, J.A., and Tijburg, L.B.M., Bioavailability of catechins from tea: the effect of milk, Eur. J. Clin. Nutr., 52, 356, 1998.
40. Rice-Evans, C.A., Miller, N.J., and Pagana, G., Structure-antioxidant activity relationships of flavonoids and phenolic acids, Free Rad. Biol. Med., 20, 933, 1996.
41. Nanjo, F., Mor, M., Goto, K., and Hara, Y., Radical scavenging activity of tea catechins and their related compounds. Biosci. Biotechnol. Biochem., 63, 1621, 1999.
42. Nakagawa, A., Beal, M.F., and Frei, B., Direct scavenging of nitric oxide and superoxide by green tea, Food Chem. Toxicol. 40, 1745, 2002.
43. Chan, M. M-Y., Ho, C.T., and Huang, H.I., Effects of three dietary phytochemicals from tea, rosemary, and tumeric on inflammation-induced nitrite production, Cancer Letts., 96:, 23, 1995.
44. Soriani, M., Rice-Evans, C.A., and Tyrell, R.M., Modulation of the UV activation of haem oxygenase, collagenase and cyclooxygenase expression by epigallocatechin in human skin cells, FEBS Letts. 439, 253, 1995.
45. Sun, J., Chu, Y.F., Wu, X., and Liu, R.I., Antioxidant and antiproliferative activities of common fruits, J. Agric. Food Chem. 50, 7449, 2002.
46. Miller, H.E., Pigelhof, F., Marquart, L., Prakash, A., and Kanter, M., Antioxidant content of whole grain breakfast cereals, fruits and vegetables, J. Am. Coll. Nutr., 19, 312S, 2000.
47. Wang, H., Cao, G., and Prior, R.L., Total antioxidant capacity of fruits, J. Agric. Food Chem. 44, 701, 1996.
48. Lee, K.W., Kim, Y.J., Kim, D.O., and Lee, C.Y., Major phenolics in apple and their contribution to the total antioxidant capacity. J. Agric. Food Chem., 51, 6516, 2003.
49. Wolfe, K., Liu, X., and Liu, R.H., Antioxidant activity of apple peels, J. Agric. Food Chem. 51, 609, 2003.
50. Liu, R.H., Health benefits of fruit and vegetables are from additive and synergistic combinations of phytochemicals, Am. J. Clin. Nutr., 78, 517S, 2003.
51. Nagasawa, T., Tabata, N., Ito, Y., Aiba, Y., Nishizawa, N., and Kitts, D.D., Dietary G-rutin suppresses glycation in tissue proteins of streptozotocin-induced diabetic rats, Mol. Cell Biochem., 252, 141, 2003.
52. Marcocci, L., Packer, L., Droy-Lefaix, M-T., Sekaki, A., and Gardes-Albert, M., Antioxidant action in ginkgo biloba extract Egb761, in Methods of Enzymology - Oxygen Radicals in Biological Systems, Vol 234, Packer, L., Ed., Academic Press, San Diego, 1994, p. 462.
53. Manach, C., Morand, C., Texiert, O., Favier, M. L., Agullo, G., Demigne, C., Regerat, F., and Remesy, C., Quercetin metabolites in plasma of rats fed diets containing rutin or quercetin, J. Nutr., 125, 1911, 1995.
54. Huang, Y.T., Hwang, J.J., Lee, P.P., Ke, F. C., Huang, C. J., Kandaswami, C., Middleton, E., and Lee, M.T., Effect of luteolin and quercetin inhibitors of tyrosine kinase on cell growth and metastasis-associated properties in A431 cells over expressing epidermal growth factor receptor, Br J. Pharmacol., 128, 999, 1999.
55. Cheng, J., Kondo, K., Suzuki, Y., Ikeda, Y., Meng, X., and Umemura, K., Inhibitory effects of total flavones of Hippophae Rhammoides L on thrombosis in mouse femoral artery and in vitro platelet aggregation, Life Sci., 72, 2263, 2003.
56. Hu, C. and Kitts, D., Antioxidant, prooxidant and cytotoxic activities of solventfractionated dandelion (Taraxacum officinale) flower extracts in vitro, J. Agric. Food Chem., 51, 301 2003.
57. Hu, C. and Kitts, D.D., Luteolin and luteolin-7-O-glucoside from dandelion flower suppress iNOS and COX-2 in RAW264.7 cells, Mol. Cell Biochem., 265, 107, 2004.
58. Wilcox, L.J., Borradaile, N.M., and Huff, M.W., Antiatherogenic properties of naringenin, a citrus flavonoid, Cardiovasc. Drug Rev., 17, 160, 1999.
59. Choi, M-S., Do, K-M, Park, Y-B., Jeon, S-M., Jeong, T-S., Lee, Y-K., Lee, M-K., and Bok, S-H., Effect of naringin supplementation on cholesterol metabolism and antioxidant status in rats fed high cholesterol with different levels of vitamin E, Ann. Nutr. Metab., 45, 193, 2001.
60. Chen, C.H., Jeong, T.S., Choi, Y.K., Hyun, B.H., Oh, G.T., Kim, E.H., Kim, J.R., Han, J.I., and Bok, S.H., Anti-atherogenic effect of citrus flavonoids, naringin and naringenin, associated with hepatic ACAT and aortic VCAM-1 and MCP-1 in high cholesterol-fed rabbits, Biochem. Biophys. Res. Commun., 284, 681, 2001.
61. Kalt, W., Forney, C., Marin, A., and Prior, R.L., Antioxidant capacity of vitamin C, phenolics and anthocyanins after fresh storage of small fruits, J. Agric. Food Chem., 47, 4638, 1999.
62. Wang, H., Nair, M.G., Strasburg, G., Chang, Y.C., Booren, A M., Gray, J.I., and DeWitt, D.L., Antioxidant and antinflammatory activities of anthocyanins and their aglycon, cyaniding form tart cherries, J. Nat. Prod., 62, 294, 1999.
63. Hu, C., Zawistowski, J., Ling, W., and Kitts, D.D., Black rice (Oryza sativa L. indica) pigmented fraction suppresses both reactive oxygen species and nitric oxide in chemical and biological model systems, J. Agric. Food Chem., 51, 5271, 2003.
64. Awika, J., Rooney, L.W., and Waniska, R.D., Properties of 3-deoxyanthocyanins from sorghum, J. Agric. Food. Chem.,52, 4388, 2004.
65. Tsuda, T., Ohshima, K., Kawakishi, S. and Osawa, T., Antioxidant pigments insolated from the seed of Phaseolus vulgaris L., J. Agric. Food Chem., 42 248, 1994.
66. Xia, M., Ling, W., Ma, J., Kitts, D.D., and Zawistowski, J., Supplementation of diets with black rice pigment fraction attenuates atherosclerotic plaque formation in apolipoprotein E deficient mice, J. Nutr., 133, 744, 2003.
67. Sato, M., Bagchi, D., Toskai, A., and Das, D.K., Grape seed proanthocyanidin reduces cardiomyocyte apoptosis by inhibiting ischemia/reperfusion-induced activation of JNK-1 and C-JUN, Free Rad. Biol. Med., 31,729, 2001.
68. Bagchi, S., Sen, C.K., Ray, S.D., Das, D.K., Bagchi, M., Preuss, H.G., and Vinson, J.A., Molecular mechanisms of cardioprotection by a novel grape seed proanthocyanidin extract, Mutat. Res., 523-524, 87, 2003.
69. Patraki, T., Bak, I., Kovacs, P., Bagchi, D., Das, D.K., and Tosaski, A., Grape seed proanthocyanidins improved cardiac recovery during reperfusion after ischemia in isolated rat hearts, Am. J. Clin. Nutr., 75, 894, 2002.
70. Paiva, S.A. and Russell, R. M., Beta-carotene and other carotenoids as antioxidants, J. Am. Coll Nutr., 18, 426, 1999.
71. Panasenko, O.M., Sharov, V.S., Briviba, K., and Sies, H., Interaction of peroxynitrite with carotenoids in human low density lipoproteins, Arch. Biochem. Biophys., 373, 302, 2003.
72. Dugas, T.R., Morel, D.W., and Harrison, E.H., Dietary supplementation with β-carotene, but not with lycopene, inhibits endothelial cell-mediated oxidation of low density lipoproteins, Free Rad. Biol. Med., 26, 1238, 1999.
73. Kritshevsky, S.B., Tell, G. S., Shimakawa, T., Dennis, B., Li, R., Kohlmeier, L., Steere, E., and Heiss, G., Provitamn A carotenoid intake and carotid artery plaques: the atherosclerosis risk in communities study, Am. J. Clin. Nutr., 68, 726, 1998.
74. Martin, K.R., Wu, D., and Meydani, M., The effects of carotenoids on the expression of cell surface adhesion molecules and binding of monocytes to human aortic endothelial cells, Atherosclerosis, 150, 265, 2000.
75. Tavani, A. and La Vecchia, C., Beta-carotene and risk of coronary heart disease, A review of observational and intervention studies, Biomed. Pharmacoltherapy, 53, 409, 1999.
76. Van Poppel, G., Epidemiological evidence for beta-carotene in prevention of cancer and cardiovascular disease, Eur J. Clin. Nutr., 50, S57, 1996.
77. Greenberg, R.E., Baron, J.A., Karagas, M.R., Stukel, T.A., Nierenberg, D.W., Stevens, M M., Mandel, J. S., and Haile, R.W., Mortality associated with low plasma concentration of beta-carotene and the effect of oral supplementation, JAMA, 275, 699, 1996.
78. Rao, A.V., Lycopene, tomatoes and the prevention of heart disease, Exp. Biol. Med., 227, 908, 2002.
79. Fuhrman, B., Elis, A., and Aviram, M., Hypocholesterolemic effect of lycopene and beta-carotene is related to suppression of cholesterol synthesis and augmentation of LDL receptor activity in macrophages, Biochem. Biophys. Res. Commun., 233, 658, 1997.
80. Fuhrman, B., Volkova, N., Rosenblat, M., and Aviram, M., Lycopene synergistically inhibits LDL oxidation in combination with vitamin E, glabridin, rosemarinic acid, carnosic acid or garlic. Antioxid. Redox Signal, 2, 491, 2000.
81. Moncada, S. and Higgs, A., The L-arginine-nitric oxide pathway. New Eng. J. Med., 329, 2002, 1993.
82. Esterbauer, H., Gebicki, J., Puhl, H., and Jurgens, G., The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Rad. Biol. Med., 13, 341, 1992.
83. Gianetti, J., Pedrinelli, R., Petrucci, R., Lazzerini, G., De Caterina, M., Bellomo, G., and De Caterina, R., Inverse association between carotid-media thickness and the antioxidant lycopene in atherosclerosis. Am. Heart J. 143, 467, 2002.
84. Klipstein-Grobusch, K., Launer, L. J., Geleijnse, J. M., Boeing, H., Hofman, A., and Witteman, J. C., Serum carotenoids and atherosclerosis, the Rottendam study, Atherosclerosis, 148, 49, 2000.
85. Rissanen, T.H., Voutilainen, S., Nyyssonen, K., Lakka, T.A., Sivenius, J., Salonen, R., Kaplan, G.A., and Salonen, J.T., Low serum lycopene concentration is associated with an excess incidence of acute coronary events and stroke: the Kuopio Ischaemic Heart Disease Risk Factor Study, Br J. Nutr., 85, 749, 2000.
86. Balestrieri, M.L., De Prisco, R., Nicolaus, B., Pari, P., Schiano Moriello, V., Strazzullo, G., Iorio, E.L., Servillo, L., and Balestrieri, C., Lycopene in association with alpha-tocopherol or tomato lipophilic extracts enhances acyl-plateletactivating factor biosynthesis in endothelial cells during oxidative stress, Free Rad. Biol. Med., 36, 1058, 2004.
87. Ivanov, V., Carr, A.C., and Frei, B., Red wine antioxidants bind to human lipoproteins and protect them from metal ion-dependent and -independent oxidation. J. Agric. Food Chem., 49, 4442, 2001.
88. Deckert, V., Desrumaux, C., Athias, A., Duverneuil, L., Palleau, V., Gambert, P., Masson, D., and Lagrost, L., Prevention of LDL alpha-tocopherol consumption, cholesterol oxidation, and vascular endothelium dysfunction by polyphenolic compounds from red wine, Atherosclerosis, 165, 41, 2002.
89. De Lange, D.W., Van Golde, P.H., Scholman, W.L.G., Kraaijenhagen, R.J., Akkerman, J.W.N., and Van De Wiel, A., Red wine and red wine polyphenolic compounds but not alcohol inhibit ADP-induced platelet aggregation, Eur. J. Intern. Med., 14, 361, 2003.
90. Whitehead, T.P., Robinson, D., Sallaawaay, S., Syms, J., and Hale, A., Effect of red wine on the antioxidant capacity of serum, Clin. Chem., 41, 32, 1995.
91. Williams, M.J., Sutherland, W.H., Whelan, A.P., McCormick, M.P., and De Jong, S.A., Acute effect of drinking red and white wines on circulating levels of inflammation-sensitive molecules in men with coronary artery disease, Metabolism, 53, 318, 2004.
92. 2release is stimulated by wine in vitro: One mechanism that may mediate the vasoprotective effects of wine, J. Nutr. Biochem., 8, 647, 1997.
93. Diebolt, M., Bucher, B., and Andrianstisohaina, R., Wine polyphenols decrease blood pressure, improve NO vasodilation and induce gene expression, Hypertension, 38, 159, 2001.
94. Landrault, N., Poucheret, P., Ravel, P., Gasc, F., Cros, G., and Teissedre, P.L., Antioxidant capacities and phenolic levels of French wines from different varieties and vintages. J. Agric. Food Chem., 49, 3341, 2001.
95. Ray, P.S., Maulik, G., Cordis, G.A., Bertelli, A.A., Bertelli, A., and Das, D.K. The red wine antioxidant resveratrol protects isolated rat hearts from ischemia reperfusion injury, Free Rad. Biol. Med., 27, 160, 1999.
96. Hung. L.M., Chen, J.K., Huang. S.S., Lee, R. S., and Su, M.J., Cardioprotective effect of resveratrol, a natural antioxidant derived from grapes, Cardiovasc Res., 47, 549, 2000.
97. Bradamante, S., Barenghi, L., Piccinini, F., Bertelli, A. A., De Jong, R., Beemster, P., and De Jong, J.W., Resveratrol provides late-phase cardioprotection by means of a nitric oxide-and adenosine-mediated mechanism, Eur. J. Pharmacol., 465, 115, 2003.
98. Fremont, L., Biological effects of resveratrol, Life Sci., 66, 663, 2000.
99. Mizutani, K., Ikeda, K., and Yamori, Y., Resveratrol inhibits AGE-s induced proliferataion and collagen synthesis activity in vascular smooth muscle cells from stroke-prone spontaneously hypertensive rats, Biochem. Biophys. Res. Comm., 274, 61, 2000.
100. Chappey, O., Dosquet, C., Wautier, M-P., and Wautier, J.L., Advanced glycation end-products, oxidative stress and vascular lesions, Eur J. Clin. Invest., 27, 97, 1997.
101. Kitts, D.D., Yuan, Y.V., Wijewickreme, A.N., and Thompson, L.U., Antioxidant activity of flaxseed lignan secoisolariciresinol diglycoside and its mammalian lignan metabolites enterodiol and enterolactone, Mol. Cell Biochem., 202, 545, 1999.
102. Sroka, Z. and Cisowski, W., Hydrogen peroxide scavenging, antioxidant and anti-radical activity of some phenolic acids. Food Chem. Toxicol., 41, 753, 2003.
103. Lai, H.H. and Yen G.C., Inhibitory effect of isoflavones on peroxynitrite-mediated low-density lipoprotein oxidation, Biosci. Biotechnol. Biochem., 66, 22, 2002.
104. Jiang, F., Jones, G.T., Husband, A.J., and Dusting, G.J., Cardiovascular protective effects of synthetic isoflavone derivatives in apolipoprotein E-deficient mice, J. Vasc. Res., 40, 276, 2003.
105. Davis, J.N., Kucuk, O., Djuric, Z., and Sarkar, F.H., Soy isoflavone supplementation in healthy men prevents NF-kappa B activation by TNF-alpha in blood lymphocytes, Free Rad. Biol. Med., 30, 1293, 2001.
106. Jenkins, D. J., Kendell, C.W., Jackson, C. J., Connelly, P.W., Parker, T., Faulkner, D., Vidgene, E., Cunnane, S.C., Leiter, L.A., and Josse, R.G., Effects of highand low-isoflavone soyfoods on blood lipids, oxidized LDL, homocysteine, and blood pressure in hyperlipidemic men and women, Am. J. Clin. Nutr., 76, 365, 2002.
107. Sanders, T.A., Dean, T.S., Grainger, D., Miller, G.J., and Wiseman, H., Moderate intakes of intact soy protein rich in isoflavones compared with ethanol-extracted soy protein increase HDL but do not influence transforming growth factor beta(1) concentrations and hemostatic risk factors for coronary heart disease in healthy subjects, Am. J. Clin. Nutr., 76, 373, 2002.
108. Nestel, P., Isoflavones: their effects on cardiovascular risk and functions, Curr. Opin. Lipidol., 14, 3, 2003.
109. 2+sensitivity in rat myocardium, Exp. Biol. Med., 227, 632, 2002.
110. Kondo, K., Suzuki, Y., Ikeda, Y. and Umemura, K. Genistein, an isoflavone included in soy, inhibits thrombotic vessel occlusion in the mouse femoral artery and in vitro platelet aggregation. Eur. J. Pharmacol., 455, 53, 2002.
111. Pan, W., Ikeda, K., Takebe, M., and Yamori, Y., Genistein, daidzein and glycitein inhibit growth and DNA synthesis of aortic smooth muscle cells from strokeprone spontaneously hypertensive rats, J. Nutr., 131, 1154, 2001.
112. Mruk, J.S., Webster, M.W., Heras, M., Reid, J.M., Grill, D.E, and Chesebro, J.H., Flavone-8-acetic acid (flavonoid) profoundly reduces platelet-dependent thrombosis and vasoconstriction after deep arterial injury in vivo, Circulation, 101, 324, 2000.
113. Sahu, S.C., Dual role of organosulfur compounds in foods: a review, J. Environ. Sci. Health, 20, 61, 2002.
114. Ali, M., Al-Qattan, K.K., Al-Enezi, F., Khanafer, R.M., Mustafa, T., Effect of allicin from garlic powder on serum lipids and blood pressure in rats fed with a high cholesterol diet, Prostaglandins Leukot. Essent. Fatty Acids, 62, 253, 2000.
115. Chernyad’eva, I.F., Shilʼnikova, S.V., Rogoza, A.N., and Kukharchuk, V.V., Dynamics of interrelationships between the content of lipoprotein particles, fibrinogen, and leukocyte count in the plasma from patients with coronary heart disease treated with Kwai, Bull. Exp. Biol. Med., 135, 436, 2003.
116. Borek, C., Antioxidant health effects of aged garlic extract, J. Nutr., 131, 1010S, 2001.
117. Banerjee, S.K., Dinda, A.K., Manchanda, S.C., and Maulik, S.K., Chronic garlic administration protects rat heart against oxidative stress induced by ischemic reperfusion injury, BMC Pharmacol., 2, 16, 2002.
118. Ackermann, R.T., Mulrow, C.D., Ramirez, G., Gardner, C.D., Morbidoni, L., and Lawrence, V.A., Garlic shows promise for improving some cardiovascular risk factors, Arch. Intern. Med., 161, 813, 2001.
119. Ali, M., Thomson, M., and Afzal, M., Garlic and onions: their effect on eicosanoid metabolism and its clinical relevance, Prostaglandins Leukot. Essen. Fatty Acids, 62, 55, 2000.
120. Tapiero, H., Townsend, D.M., and Tew, K., Organosulfur compounds from alliaceae in the prevention of human pathologies, BioMed. Pharmacother., 58, 183, 2004.
121. Thomson, M., Mustafa, T., and Ali, M., Thromboxane-B2 levels in serum of rabbits receiving a single intravenous dose of aqueous extract of garlic and onion, Prostaglandins Leukot. Essen. Fatty Acids, 63, 217, 2000.
122. Slowing, K., Ganado, P., Sanz, M., Ruiz, E., and Tejerina, T., Study of garlic extracts and fractions on cholesterol plasma levels and vascular reactivity in cholesterol-fed rabbits, J. Nutr. 131, 994S, 2001.
123. Focke, M., Feld, A., and Lichtenthaler, K., Allicin, a naturally occurring antibiotic from garlic, specifically inhibits acetyl-CoA synthetase, FEBS Lett 26, 106, 1990.
124. Efendy, J.L, Simmons, D.L., Campbell, G.R., and Campbell, J.H., The effect of the aged garlic extract “Kyolic,” on the development of experimental atherosclerosis, Atherosclerosis, 132, 37, 1997.
125. Kwon, M.-J., Song, Y.-S., Choi, M.-S., Park, S.-J., Jeong, K.-S., and Song, Y.-O., Cholesteryl ester transfer protein activity and atherogenic parameters in rabbits supplemented with cholesterol and garlic powder, Life Sci., 72, 2953, 2003.
126. Yin, M.C., Tsao, S.M., and Lin, M.C., Protective action on human LDL against oxidation and glycation by four organosulfur compounds derived from garlic, Lipids, 38, 219, 2003.
127. Loy, M. and Rovlin, R., Garlic and cardiovascular disease, Nutr. Clin. Care, 3, 145, 2000.
128. Gupa, N. and Porter, T.D., Garlic and garlic-derived compounds inhibit human squalene monooxygenase, J. Nutr., 131, 1662, 2003.
129. Liu, L. and Yeh, Y., S-Alk(en)yl cysteines of garlic inhibit cholesterol synthesis by deactivating HMG-CoA reductase in cultured rat hepatocytes, J. Nutr., 132, 1129, 2002.
130. Teranishi, K., Apitz-Castro, R., Robson, S.C., Romano, E., and Cooper, D.K., Inhibition of baboon platelet aggregation in vitro and in vivo by the garlic derivative, ajoene, Xenotransplant, 10, 374, 2003.
131. Apitz-Castro, R., Escalanate, J., Vargas, R., and Jain, M.K., Ajoene, the antiplatelet principle of garlic, synergistically potentiates the anti-aggregatory action of prostacyclin, forskolin, indomethacin and dypridamole on human subjects, Thromb Res., 42, 303, 1986.
132. Change, H.S., Yamato, O., Sakai, Y., Yamasaki, M., and Maede, Y., Acceleration of superoxide generation in polymorphonuclear leukocytes and inhibition of platelet aggregation by alk(en)yl thiosulfates derived from onion and garlic in dogs and humans, Prostaglandins Leukot. Essent. Fatty Acids, 70, 77, 2004.
133. Kitts, D.D. and Popovich, D.G., Ginseng, in Performance Functional Foods, Watson D.H. (ed), Woodhead Publishing Ltd. Cambridge England, 2003, p. 78.
134. Zhang, D., Ysuda, T., Yu, Y., Zheng, P., Kawabata, T., Ma, Y., and Okada, S., Ginseng extract scavenges hydroxyl radical and protects unsaturated fatty acids from decomposition caused by iron-mediated lipid peroxidation, Free Rad. Biol. Med., 20, 145, 1996.
135. Kitts, D.D., Wijewickreme, A.N., and Hu, C., Antioxidant properties of a North American ginseng extract, Mol. Cell Biochem., 203, 1, 2000.
136. Hu, C. and Kitts, D.D., Free radical scavenging capacity as related to antioxidant activity and ginsenoside composition of Asian and North American ginseng extracts. J. Am. Chem. Soc., 78, 249, 2001.
137. Kim, H.S. and Lee, B.M., Protective effects of antioxidant supplementation on plasma lipid peroxidation in smokers, J. Toxicol. Environ. Health, 63, 583-589, 2001.
138. Liu, Z., Luo, X., Sun, Y., Chen, Y., and Wang, Z., Can ginsenosides protect human erthrocytes against free-radical induced hemolysis? Biochim. Biophys. Acta 1572, 58, 2002.
139. Bae, E.A., Han, M.J., Choo, M.K., Park, S.Y., and Kim, D.H., Metabolism of 20(S)-and 20(R)-ginsenoside Rg3 by human intestinal bacteria and its relation to in vitro biological activities, Biol. Pharmacol.Bull., 25, 58, 2001.
140. Popovich, D.G. and Kitts, D.D., Generation of ginsenosides Rg3 and Rh2 from North American ginseng. Phytochemistry 65, 337, 2004.
141. Popovich, D.G. and Kitts D.D., Ginsenosides 20(S)-protopanaxadiol and Rh2 reduce cell proliferation and increase sub-G1 cells in two cultured intestinal cell lines, Int-407 and Caco-2, Can. J. Physiol. Pharmacol., 82,183, 2004.
142. Bae, E.A., Choo, M.K., Park, E.K., Park, S.Y, Shin, H.Y., and Kim, D.H., Metabolism of ginsenoside Rc by human intestina bacteria and its related antiallergic activity, Biol. Pharmaceut. Bull. 25, 743, 2002.
143. Oh, G.S., Pae, H.O., and Cho, B.M., 20(S)-Protopanaxatriol, one of ginsenoside metabolites inhibits inducible nitric oxide synthase and cyclooxygenase-2 expressions through inactivation of nuclear factor-kB in RAW 264.7 macrophages stimulated with lipopolysaccharides, Cancer Lett., 205, 23, 2004.
144. Park, E.K., Choo, M.K., Oh, J.K., Ryu, J.H., and Kim, D.H., Ginsenoside Rh2 reduces ischemic brain injury in rats, Biol. Pharmacol. Bull., 27, 433, 2003.
145. Keum, Y.S., Han, S.S., Chun, K.S., Park, K.K., Park, J.H., Lee, S.K., and Surh, Y.J., Inhibitory effects of ginsenoside Rg3 on phorbol-ester-induced cyclooxygenase-2 expression, NFKB activation and tumor promotion, Mutat Res., 523, 75, 2003.
146. Packer, J.E., Slater, T.F., and Wilson, R.L., Direct observation of a free radical interaction between vitamin E and vitamin C., Nature, 278, 737, 1979.
147. Kagan V.E., Serbinova, E.A., Forte, T., Scita, G., and Packer, L., Recycling of vitamin E in human low-density lipoproteins, J. Lipid Res., 33, 385, 1992.
148. Packer, J.E., Weber, S., and Rimbach, G., Molecular aspects of alpha tocotrienol antioxidant action and cellular signaling, J. Nutr., 131, 369S, 2001.
149. Chan, A.C., Tran, K., Raynor, T., Ganz, P.R., and Chow, C.K., Regeneration of vitamin E in human platelet, J. Biol. Chem., 266, 17290, 1990.
150. Constantinescu, A., Han, D., and Packer, L., Vitamin E recycling in human erythrocyte membranes, J. Biol. Chem., 268, 10906, 1993.
151. Omenn, G.S., Goodman, G.E., Thornquist, M.D. et al., Effects of a combination of beta-carotene and vitamin A on lung cancer and cardiovascular disease, New Engl. J. Med., 334, 1150, 1996.
152. Chen, H. and Tappel. A., Protection by multiple antioxidants against lipid peroxidation in rat liver homogenates, Lipids, 31, 47, 1996.
153. Abbey, M., Nestell, P.J., and Baghurst, P.A., Antioxidant vitamins and low density lipoprotein oxidation, Am. J. Clin. Nutr., 58, 525, 1993.
154. Jia, Z.S., Zhou, B., Yang, L, Wu, L.M., and Liu, Z.L., Antioxidant synergism of tea polyphenols and alpha-tocopherol against free radical induced peroxidation of linoleic acid in solution, J. Chem. Soc. Perkin-Transaction., 4, 911, 1998.
155. Hu, C and Kitts, D.D., Evaluation of antioxidant activity of epigallocatechin gallate in biphasic model systems in vitro, Mol. Cell Biochem., 218, 147, 2001.
156. Lotito, S.B and Fraga, C G., Catechins delay lipid oxidation and alpha tocopherol and beta-carotene depletion following ascorbate depletion in human plasma, Proc. Soc. Exp. Biol. Med., 225, 32, 2000.
157. Zhu, Q.Y., Huang, Y., Tsang, D., and Chen, Z.-Y., Regeneration of alpha tocopherol in human low-density lipoprotein by green tea catechin, J. Agric. Food Chem., 47, 2020, 1999.
158. Vieira, O., Laranginka, J., Madeira, V., and Almeida, L., Cholesterol ester hydroperoxide formation in myoglobin-catalyzed low-density lipoprotein oxidation: concerted antioxidant activity of caffeic and p-coumaric acids with ascorbate, Biochem. Pharmacol., 55, 333, 1998.
159. Nanjo, F., Honda, M., Okushio, K., Matsumoto, N., Ishigaki, F., Ishigami, Y., and Hara, Y., Effects of dietary tea catechins on alpha-tocopherol levels, lipid peroxidation, and erythrocyte deformability in rats fed on high palm oil and peril oil diets, Biol. Pharm. Bull., 16, 1156, 1993.
160. Miura, Y., Chiba T., Miura S., Tomita, I., Umegaki, K., Ikeda M., and Tomita, T., Green tea polyphenols (flavan-3-ols) prevent oxidative modification of low density lipoproteins: and ex vivo study in humans, J. Nutr. Biochem., 11, 216, 2000.
161. Deckert, V., Desrumauz, C., Athias, A., Durerneuil, L., Palleau, V., Gambert, P., Masson, D., and Lagrost, L., Prevention of LDL alpha-tocopherol consumption, cholesterol oxidation and vascular endothelium dysfunction by polyphenolic compounds from red wine, Atherosclerosis, 165, 41, 2002.
162. Fuhrman, B., Volkova, N., Rosenblat, M., and Aviram, M., Lycopene synergistically inhibits LDL oxidation in combination with vitamin E, glabridin, rosemarinic acid, carnosic acid or garlic, Antioxid. Redox. Signal, 2, 491, 2000.
163. Vinson, J.A., Hu, S.J., Jung, S., and Stanski, A., A citrus extract plus ascorbic acid decreases lipids, lipid peroxides and lipoprotein oxidative susceptibility and atherosclerosis in hypercholesterolemic hamster. J. Agric. Food Chem., 46, 1453, 1998.
164. Reddy, A.C.P. and Lokesh, B.R., Alterations in lipid peroxidation in rat liver by dietary n-3 fatty acids: modulation of anti-oxidant enzymes by curcumin, eugenol and vitamin E, J. Nutr. Biochem., 5, 181, 1994.
165. Alder, A.J. and Holub, B.J., Effect of garlic and fish oil supplementation on serum lipid and lipoprotein concentrations in hypercholesterolemic men, Am. J. Clin. Nutr., 65, 445, 1997.
166. Pignatelli, P., Pulcenelli, F.M., Celestine, A., Lenti, L., Ghisellin A., Gazzanega, P.P., and Violi, F., The flavonoids quercetin and catechin synergistically inhibit platelet function by antagonizing the intracellular production of hydrogen peroxide, Am. J. Clin. Nutr., 72, 1150, 2000.
167. Stahl, W., Junghans, A., deBoer, B., Driomina, E.S., Briviba, K., and Sies, H., Carotenoid mixtures protect multimamellar liposomes against oxidative damage: synergistic effects of lycopene and luein, FEBS Lett., 427, 305, 1998.
168. Hurell, R.F., Reddy, M., and Cook, J.D., Inhibition of non-haem iron absorption in man by polyphenolic containing beverages, Br. J. Nutr., 81, 289, 1999.
169. Laudicina, D.C. and Marnett, L.J., Enhancement of hydroperoxide-dependent lipid peroxidation in rat microsomes by ascorbic acid, Arch. Biochem. Biophys., 278, 73, 1990.
170. Laughton, M.J., Halliwell, B., Evans, P.J., and Hoult, J.R.S., Antioxidant and prooxidant actions of plant phenolics, quercetin, gossypol and myricetin, Biochem. Pharmacol., 38, 859, 1989.
171. Hu, C. and Kitts, D.D., Studies on the antioxidant activity of Echinacea root extract, J. Agric. Food Chem., 48, 1466, 2000.
172. Cao, G., Sofic, E., and Prior, R.L., Antioxidant and prooxidant behavior of flavonoids: structure-activity relationships, Free Rad. Biol. Med., 22, 749, 1997.
173. Bowry, V.W. and Ingold, K.U., The unexpected role of vitamin E in the peroxidation of human low-density lipoprotein, Acc. Chem. Res., 32, 27, 1998.
174. Gey, K.F., Puska, P., Jorden, P.K, and Moser, U., Inverse correlation between plasma plasma vitamin E and mortality from ischemic heart disease in a crosscultural epidemiology, Am. J. Clin. Nutr., 53, 326, 1992.
175. Knipping. G., Rothneder, M., Strriegly, G., and Esterbauder, H., Antioxidants and resisitance against oxidation of procine LDL subfractions, J. Lipid Res., 31, 1965, 1990.
176. Hodis, H.N., Mack, W.J., La Bree, L., Cashin-Hemphill, L., Sevanian, A., Johnson, R., and Azen, S.P., Serial coronary angiographic evidence that antioxidant vitamin intake reduces progression of coronary artery atherosclerosis, J. Am. Med. Assoc., 273, 1849, 1995.
177. Reaven, P.D., Khou, A., Beltz, W.F., Parthasarathy, S., and Witztum, J.L., Effect of dietary antioxidant combinations in humans. Protection of LDL by vitamin E but not beta carotene, Arteriosclerosis Thrombosis, 13, 590, 1993.
178. Krichevsky, S.B., Shimakawa, T., Tell, G.S., Dennis, B., Carpenter, M., Echfeldt, J.H., Peacher-Ryan, H., and Heiss, G., Dietary antioxidants and carotid artery wall thickness: The ARIC study, Circulation, 92, 2142, 1995.
179. Gey, K.F., Brubacker, G.B., and Stahelin, H.B., Plasma levels of antioxidant vitamins in relation to ischemic heart disease and cancer, Am. J. Clin. Nutr., 45, 1368, 1987.
180. Tousoulis, D., Davies, G., and Toutouzas, P., Vitamin C increase nitric oxide availability in coronary heart atherosclerosis, Ann. Intern. Med., 131, 156, 1999.
181. Osganian, S.K., Stampfer, M.J., Rimm, E., Spiegelman, D., Hu, F.B., Mauson, J.E., and, Willett, W.C., Vitamin C and risk of heart disease in women, J. Am. Coll. Cardio., 42, 246, 2003.
182. Holub, B.J., Omega-3 fatty acids in cardiovascular care, Can. Med. Assoc. J., 166, 608, 2002.
183. Schoene, H.W., Vitamin E and omega-3 fatty acids: effecting platelet responsiveness. Nutrition, 17, 793, 2001.